Company Performance Metrics
Stephen Pennington: Founder and Chief of Scientific Affairs
Atturos was founded in 2014 as a spin-out company from University College Dublin with the ambition to develop and commercialize advanced diagnostics solutions to enable clinicians and patients make better decisions. Leveraging extensive expertise in mass spectrometry, proteomics, and clinical research, Atturos is focussed on the clinical and
commercial translation of their lead product, the OCProDx test. This novel multimarker test is being developed to address a significant unmet need in the treatment of prostate cancer. Supported in part by a prestigious EU Horizon 2020 SME Instrument award the Atturos Leadership Team are working closely with multiple stakeholders across the clinical, scientific, and business community to drive the rapid growth and development of the company. For a summary of their plans click here. The Atturos team are unashamedly ambitious in their plans for the company’s growth, however conscious that the result of the tests they are developing will influence the clinical decisions that change patients lives. They apply integrity to all they do in close association with patients and clinicians.
